Association of visceral and subcutaneous adiposity with tumor stage and Fuhrman grade in renal cell carcinoma

Abstract Higher BMI has been associated with lower tumor stage and grade and improved survival in renal cell cancer (RCC). BMI cannot distinguish between visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT). We examined associations of BMI, VAT, SAT, total adipose tissue (TAT) and rel...

Full description

Bibliographic Details
Main Authors: J. S. F. Maurits, J. P. M. Sedelaar, K. K. H. Aben, L. A. L. M. Kiemeney, A. Vrieling
Format: Article
Language:English
Published: Nature Portfolio 2022-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-20877-2
_version_ 1797996117330231296
author J. S. F. Maurits
J. P. M. Sedelaar
K. K. H. Aben
L. A. L. M. Kiemeney
A. Vrieling
author_facet J. S. F. Maurits
J. P. M. Sedelaar
K. K. H. Aben
L. A. L. M. Kiemeney
A. Vrieling
author_sort J. S. F. Maurits
collection DOAJ
description Abstract Higher BMI has been associated with lower tumor stage and grade and improved survival in renal cell cancer (RCC). BMI cannot distinguish between visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT). We examined associations of BMI, VAT, SAT, total adipose tissue (TAT) and relative VAT (rVAT) with tumor stage and grade in RCC patients. In a Dutch multicenter population-based historical cohort study 1039 RCC patients diagnosed between 2008 and 2012 were assessed for VAT and SAT using Computed Tomography images at L3. Sex-stratified multinomial logistic regression analyses were performed (linearly per 10-unit increase) between BMI, VAT, SAT, TAT and relative VAT (rVAT) with tumor stage and Fuhrman grade. Higher VAT, TAT and rVAT were associated with a lower risk of stage IV versus stage I in males (OR 0.93; 95%CI 0.91–0.96, OR 0.95; 95%CI 0.93–0.98, OR 0.97; 95%CI 0.96–0.99, respectively). Females showed similar associations, but only higher VAT was statistically significantly associated with reduced risk of stage IV (OR 0.95 95%CI 0.89–1.00). No associations with grade, SAT or BMI were found. In conclusion, higher VAT and TAT was associated with lower risk of stage IV RCC. This might be due to weight loss or cancer cachexia in stage IV patients.
first_indexed 2024-04-11T10:12:25Z
format Article
id doaj.art-060a3bf6554a4e179d37e7fb1fa02eff
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-11T10:12:25Z
publishDate 2022-10-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-060a3bf6554a4e179d37e7fb1fa02eff2022-12-22T04:30:03ZengNature PortfolioScientific Reports2045-23222022-10-011211810.1038/s41598-022-20877-2Association of visceral and subcutaneous adiposity with tumor stage and Fuhrman grade in renal cell carcinomaJ. S. F. Maurits0J. P. M. Sedelaar1K. K. H. Aben2L. A. L. M. Kiemeney3A. Vrieling4Department for Health Evidence (Mailbox 133), Radboud University Medical CenterDepartment of Urology, Radboud University Medical CenterDepartment for Health Evidence (Mailbox 133), Radboud University Medical CenterDepartment for Health Evidence (Mailbox 133), Radboud University Medical CenterDepartment for Health Evidence (Mailbox 133), Radboud University Medical CenterAbstract Higher BMI has been associated with lower tumor stage and grade and improved survival in renal cell cancer (RCC). BMI cannot distinguish between visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT). We examined associations of BMI, VAT, SAT, total adipose tissue (TAT) and relative VAT (rVAT) with tumor stage and grade in RCC patients. In a Dutch multicenter population-based historical cohort study 1039 RCC patients diagnosed between 2008 and 2012 were assessed for VAT and SAT using Computed Tomography images at L3. Sex-stratified multinomial logistic regression analyses were performed (linearly per 10-unit increase) between BMI, VAT, SAT, TAT and relative VAT (rVAT) with tumor stage and Fuhrman grade. Higher VAT, TAT and rVAT were associated with a lower risk of stage IV versus stage I in males (OR 0.93; 95%CI 0.91–0.96, OR 0.95; 95%CI 0.93–0.98, OR 0.97; 95%CI 0.96–0.99, respectively). Females showed similar associations, but only higher VAT was statistically significantly associated with reduced risk of stage IV (OR 0.95 95%CI 0.89–1.00). No associations with grade, SAT or BMI were found. In conclusion, higher VAT and TAT was associated with lower risk of stage IV RCC. This might be due to weight loss or cancer cachexia in stage IV patients.https://doi.org/10.1038/s41598-022-20877-2
spellingShingle J. S. F. Maurits
J. P. M. Sedelaar
K. K. H. Aben
L. A. L. M. Kiemeney
A. Vrieling
Association of visceral and subcutaneous adiposity with tumor stage and Fuhrman grade in renal cell carcinoma
Scientific Reports
title Association of visceral and subcutaneous adiposity with tumor stage and Fuhrman grade in renal cell carcinoma
title_full Association of visceral and subcutaneous adiposity with tumor stage and Fuhrman grade in renal cell carcinoma
title_fullStr Association of visceral and subcutaneous adiposity with tumor stage and Fuhrman grade in renal cell carcinoma
title_full_unstemmed Association of visceral and subcutaneous adiposity with tumor stage and Fuhrman grade in renal cell carcinoma
title_short Association of visceral and subcutaneous adiposity with tumor stage and Fuhrman grade in renal cell carcinoma
title_sort association of visceral and subcutaneous adiposity with tumor stage and fuhrman grade in renal cell carcinoma
url https://doi.org/10.1038/s41598-022-20877-2
work_keys_str_mv AT jsfmaurits associationofvisceralandsubcutaneousadipositywithtumorstageandfuhrmangradeinrenalcellcarcinoma
AT jpmsedelaar associationofvisceralandsubcutaneousadipositywithtumorstageandfuhrmangradeinrenalcellcarcinoma
AT kkhaben associationofvisceralandsubcutaneousadipositywithtumorstageandfuhrmangradeinrenalcellcarcinoma
AT lalmkiemeney associationofvisceralandsubcutaneousadipositywithtumorstageandfuhrmangradeinrenalcellcarcinoma
AT avrieling associationofvisceralandsubcutaneousadipositywithtumorstageandfuhrmangradeinrenalcellcarcinoma